title: Words of wisdom. Re: Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma.
authors: Loyola University Medical Center, Maywood, IL 60153, USA. rflanig@lumc.edu
authors: Robert C
authors: RC
authors: Flanigan
authors: Anthony
authors: A
authors: Polcari
authors: Anthony
authors: A
authors: Pulcari